Evogene Ltd.

29
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IL0011050551
USD
0.85
-0.09 (-9.3%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Evogene Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-13.00
-18.00
-25.00
-29.00
-30.00
-26.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-1.00
-3.00
0.00
0.00
1.00
-1.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-13.00
-19.00
-21.00
-23.00
-24.00
-19.00
Cash Flow from Investing Activities
17.00
9.00
-4.00
13.00
-20.00
9.00
Cash Flow from Financing Activities
-6.00
4.00
18.00
9.00
30.00
20.00
Net Cash Inflow / Outflow
0.00
-5.00
-8.00
-3.00
-13.00
11.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
-2.00
1.00
1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Evogene Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-13.4590000000298
267.076
-280.00
-105.04%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-1.25300000000277
21.01
-22.00
-105.96%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-13.5020000000299
324.262
-337.00
-104.16%
Cash Flow from Investing Activities
17.7380000000392
-34.862
51.00
150.88%
Cash Flow from Financing Activities
-6.6020000000146
-263.633
257.00
97.50%
Net Cash Inflow / Outflow
0
32.452
-32.00
-100.00%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
6.685
-6.00
-100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 31.46% vs 8.70% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-13.50
-19.70
31.46%